Bortezomib 68001-0541
Product NDC
68001-0541- Manufacturer
- Bluepoint Laboratories
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 31, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209622
Need to source Bortezomib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bortezomib | 3.5 mg/3.5mL |
Drug Class
Proteasome Inhibitor [EPC]Proteasome Inhibitor [EPC]Proteasome Inhibitors [MoA]
Packaging Options(1)
1 VIAL, SINGLE-USE in 1 CARTON (68001-541-36) / 3.5 mL in 1 VIAL, SINGLE-USE